HM Payson & Co’s DermTech, Inc. Common Stock DMTK Stock Holding History

HM Payson & Co’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-125	Closed	-$180	–	1052
2023 Q3	$180	Hold	125	–	–	﹤0.01%	989
2023 Q2	$325	Hold	125	–	–	﹤0.01%	975
2023 Q1	$460	Hold	125	–	–	﹤0.01%	983
2022 Q4	$221	Hold	125	–	–	﹤0.01%	915
2022 Q3	$0	Hold	125	–	–	﹤0.01%	1100
2022 Q2	$1K	Hold	125	–	–	﹤0.01%	1026
2022 Q1	$2K	Hold	125	–	–	﹤0.01%	1002
2021 Q4	$2K	Hold	125	–	–	﹤0.01%	1028
2021 Q3	$4K	Hold	125	–	–	﹤0.01%	934
2021 Q2	$5K	Hold	125	–	–	﹤0.01%	901
2021 Q1	$6K	Hold	125	–	–	﹤0.01%	934
2020 Q4	$4K	Hold	125	–	–	﹤0.01%	961
2020 Q3	$1K	Hold	125	–	–	﹤0.01%	1021
2020 Q2	$2K	Buy	+125	New	+$1.63K	﹤0.01%	835

Other funds holding DMTK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TCBWMS

Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return

HM Payson & Co's DMTK Position: Q4 2023 in Review

HM Payson & Co sold out of DermTech, Inc. Common Stock (DMTK) in Q4 2023, closing a stake of 125 shares — an estimated $180 sold.

HM Payson & Co first reported a position in DMTK in Q2 2020 and held it in 14 quarters. The position peaked at $6K in Q1 2021. 77 funds tracked by Wall St. Rank hold DMTK as of Q4 2023.

HM Payson & Co reported no remaining DermTech, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
HM Payson & Co sold 125 DermTech, Inc. Common Stock shares in Q4 2023, an estimated $180.
HM Payson & Co first reported a position in DermTech, Inc. Common Stock in Q2 2020 and held it in 14 quarters.
HM Payson & Co's DermTech, Inc. Common Stock position peaked at $6K in Q1 2021.
77 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q4 2023.

Based on HM Payson & Co's 13F filing for Q4 2023, filed 13 Feb 2024.